Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
Upturn AI SWOT - About
Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (PILL)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: PILL (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type ETF | Historic Profit 40.03% | Avg. Invested days 46 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  4.0 | ETF Returns Performance  5.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Volume (30-day avg) - | Beta 1.79 | 52 Weeks Range 3.60 - 10.53 | Updated Date 06/29/2025 |
52 Weeks Range 3.60 - 10.53 | Updated Date 06/29/2025 |
Upturn AI SWOT
Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF
ETF Overview
Overview
The Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (PILL) seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P Pharmaceuticals Select Industry Index. It focuses on the pharmaceutical and medical industries.
Reputation and Reliability
Direxion is a well-known provider of leveraged and inverse ETFs, generally considered reliable within their specific market segment.
Management Expertise
Direxion has a specialized team focused on managing leveraged and inverse ETFs. Their expertise lies in maintaining the daily leverage targets.
Investment Objective
Goal
The ETF aims to achieve 3x the daily performance of the S&P Pharmaceuticals Select Industry Index.
Investment Approach and Strategy
Strategy: The ETF employs a leveraged strategy, using derivatives such as swaps, futures contracts, and options to amplify the returns of the underlying index on a daily basis.
Composition Primarily holds derivatives and other financial instruments designed to deliver 3x the daily performance of the index, alongside cash or cash equivalents for collateral purposes.
Market Position
Market Share: Data unavailable.
Total Net Assets (AUM): 40.94
Competitors
Key Competitors
- ProShares Ultra Nasdaq Biotechnology (BIB)
- ProShares Ultra Healthcare (RXL)
Competitive Landscape
The leveraged ETF industry is competitive, with several providers offering similar products across different sectors. PILL's advantage lies in its specific focus on the pharmaceutical and medical sectors, but it faces competition from other leveraged healthcare and biotechnology ETFs. The leveraged nature adds high risk.
Financial Performance
Historical Performance: Historical performance data is not relevant for leveraged ETFs, as they are designed for daily returns and long-term returns can deviate significantly due to compounding and volatility.
Benchmark Comparison: Benchmark comparison is most relevant on a daily basis, aiming to achieve 3x the daily performance of the S&P Pharmaceuticals Select Industry Index. Long-term comparisons are less meaningful.
Expense Ratio: 0.95
Liquidity
Average Trading Volume
The average daily trading volume for PILL is typically moderate, meaning that large trades could impact price.
Bid-Ask Spread
The bid-ask spread can be wider than more liquid ETFs, increasing trading costs.
Market Dynamics
Market Environment Factors
Economic indicators, healthcare policy changes, FDA approvals, pharmaceutical company earnings, and overall market sentiment all influence PILL.
Growth Trajectory
PILL's growth is directly tied to the performance of the pharmaceutical and medical sectors. It is also sensitive to changes in market volatility.
Moat and Competitive Advantages
Competitive Edge
PILL's advantage lies primarily in its specific 3x leveraged exposure to the pharmaceutical and medical sectors. It offers a tactical tool for investors with a short-term bullish outlook on these industries. However, the daily reset feature and the impact of compounding make it unsuitable for long-term buy-and-hold strategies. PILL is a specialized product designed for experienced traders.
Risk Analysis
Volatility
PILL is highly volatile due to its 3x leverage, meaning that it can experience significant price swings in either direction.
Market Risk
The underlying assets are subject to market risk, and the leveraged nature of the ETF amplifies these risks. Compounding can cause significant deviation from the target index over time.
Investor Profile
Ideal Investor Profile
The ideal investor for PILL is an experienced trader with a high-risk tolerance who understands the complexities of leveraged ETFs and has a short-term investment horizon.
Market Risk
PILL is best suited for active traders seeking short-term tactical exposure. It is unsuitable for long-term investors or passive index followers.
Summary
The Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (PILL) offers a leveraged investment in the pharmaceutical and medical sectors. It is designed for short-term tactical trading rather than long-term investment due to the daily reset feature and potential for compounding errors. PILL is only suitable for experienced traders with a high-risk tolerance. Investors should carefully consider their investment objectives and risk appetite before investing in PILL.
Peer Comparison
Sources and Disclaimers
Data Sources:
- DirexionShares.com
- ETF.com
- Yahoo Finance
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Investment decisions should be based on individual circumstances and consultation with a qualified financial advisor. Leveraged ETFs are complex instruments and may not be suitable for all investors.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is a modified equal-weighted index that is designed to measure performance of the stocks, defined as pharmaceutical and medical stocks, comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.